• JPD200_slider_2

Service

 

Our (e)Books and (e)Journals

IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.

  • IOS_30_Logo_11716_FINAL2
  • go-to-ejournals
  • kudos_static_310_x_62
  • Rehab Journals
  • Neuro Journals
  • Go to IOS Press Ebooks
  • Millpress and Delft University Press imprints IOS Press
  • Statement side banner

Service

 

Significant Impact Factor Gains for AI and Computer Sciences Journals

June 23, 2017 - IOS Press announces significant Impact Factor growth in its journals in artificial intelligence, computer & communications sciences and mathematics, according to the 2016 Journal Citation Reports® (JCR) released by Clarivate Analytics this month.

June 23, 2017

Brain Stimulation Protocol Reduces Spasticity in Spinal Cord Injury Patients

June 19, 2017 - Amsterdam, NL – Spasticity, uncontrolled muscle contractions, is a common disorder experienced by patients with spinal cord injuries (SCI). Previous studies have shown that excitatory repetitive transcranial magnetic stimulation (rTMS) can reduce spasticity. In a new study published in Restorative Neurology and Neuroscience, researchers found that a protocol of rTMS, excitatory intermittent theta burst stimulation (iTBS), was successful in reducing spasticity in patients with SCI and therefore may be a promising therapeutic tool.

June 19, 2017

Researchers Seek Biomarker to Assess Spinal Muscular Atrophy Treatment

June 16, 2017 - Amsterdam, NL – Spinal muscular atrophy (SMA) is the leading genetic cause of death in infants, affecting 1 in 11,000 live births. As promising new therapies such as those directly targeting survivor motor neuron (SMN) are entering clinical trials for infants, children, and adults with SMA, researchers are searching for biomarkers in blood that can monitor their effectiveness. Investigators now report in the Journal of Neuromuscular Diseases that SMN levels in blood do not track SMN levels in motor neurons, and therefore are not an informative biomarker for SMN-modulating therapies that are delivered intrathecally. Beyond providing important information for SMA trial planning going forward, their results also highlight the importance of carefully validating specific biomarkers in a preclinical trial situation.

June 16, 2017

Gap in health care for Alzheimer´s disease patients who live alone

June 16, 2017 - Stockholm, Sweden - The patients who live alone do not receive the same extent of diagnostic investigations and anti-dementia treatment as those who are co-habiting. On the other hand, they were treated more frequently with antidepressants, antipsychotics and sedative drugs.

June 16, 2017